1. [PDF] RIVM rapport 000002 001 BMR vaccin bij 14 maanden oude kinderen ...
In deze studie is de gebruikelijke en in de bijsluiter geadviseerde subcutane toedieningsroute van het BMR vaccin vergeleken met intramusculaire toediening, ...
2. Vaccine elicitation of high mannose-dependent neutralizing ...
Summary. Induction of broadly neutralizing antibodies (bnAbs) that target HIV-1 envelope (Env) is a goal of HIV-1 vaccine development.
Induction of broadly neutralizing antibodies (bnAbs) that target HIV-1 envelope (Env) is a goal of HIV-1 vaccine development. A bnAb target is the Env third variable loop (V3)-glycan site. To determine if immunization could induce antibodies to the ...
3. [PDF] VACCINE INFORMATION - http
11 nov 2013 · ... Dunlop et al., 2008; Peace & Constantin, 2015). Therefore, it might lead to more resistance towards the Covid-19 vaccination. Page 7. 7.
4. Vaccination as investment in human capital - Oxford Academic
20 apr 2023 · Vaccines can be regarded by individuals as investments in human capital that can yield future returns in the form of the direct utility of health.
5. [PDF] The National Immunisation Programme in the Netherlands - RIVM
Hawkes D, Benhamu J, Sidwell T, Miles R, Dunlop RA. Revisiting adverse reactions to vaccines: A critical appraisal of Autoimmune Syndrome Induced by ...
6. COVID-19 pharmacy vaccine locations - Ontario.ca
4 dagen geleden · Most pharmacies that offer vaccines will have both COVID-19 vaccines and flu shots available (check with your pharmacy before you go).
Find your closest pharmacy to get a COVID-19 vaccine.
7. Beyond Suppression: Peripheral T Cell Responses to Vaccination in ...
... COVID-19 vaccination [13]. Importantly, new findings involving vaccine ... Zhang, Z.; Mateus, J.; Coelho, C.H.; Dan, J.M.; Moderbacher, C.R.; Gálvez ...
Alimentary tract inflammation in inflammatory bowel disease (IBD) is treated by systemically administered drugs that alter fundamental host immune responses. Biologics that target tumor necrosis factor (TNF) are first-line biologics in IBD, used widely for their effectiveness, steroid-sparing quality, and lower cost. While they enable a significant proportion of patients to achieve clinical remission, they carry an increased risk of infection and poor serological responses to vaccination. Conversely, our understanding of adaptive T cell responses in anti-TNF-treated IBD patients remains limited. The introduction of COVID-19 vaccines has prompted research that both challenges and refines our view on immunomodulatory therapy and its potential implications for immunity and protection. Here, we review these emergent findings, evaluate how they shape our understanding of vaccine-induced T cell responses in the context of anti-TNF therapy in IBD, and provide a perspective highlighting the need for a holistic evaluation of both cellular and humoral immunity in this population.
8. [PDF] ACTIVE IMMUNIZATION AGAINST GONADOTROPIN-RELEASING ...
peptide, in particular for producing these vaccines and vaccination kit relating thereto. ... beetje druk, is het er dan toch van gekomen. Rob, bedankt voor de ...
9. [PDF] HIV-1 VACCINE DEVELOPMENT: STUDIES IN MACAQUE MODELS
Daniel, M.D., lI, Y., Naldu, Y.M., Durda, P.J .. Schmidt, O.K., Troup, C.D. ... Dunlop, N., Nara, P.l., Barbas, 111. Effident neutralization of primary ...
10. [PDF] On the vaccination of shrimp against white spot syndrome virus
Poulos, B. T., Pantoja, C. R., Bradley-Dunlop, D., Aguilar, J. and Lightner, D. V. (2001). Development and application of monoclonal antibodies for the ...
11. Carbohydrate vaccines: developing sweet solutions to sticky situations?
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. ... Dan Li; Bin ...
Antibiotic drug resistance has increased interest in developing vaccines against carbohydrate structures on the surface of bacterial pathogens. Astronomo and Burton examine recent progress in the identification, synthesis and evaluation of glycan epitopes found not only on bacteria, but also on protozoa, helminths, viruses, fungi and cancer cells for vaccine design. Recent technological advances in glycobiology and glycochemistry are paving the way for a new era in carbohydrate vaccine design. This is enabling greater efficiency in the identification, synthesis and evaluation of unique glycan epitopes found on a plethora of pathogens and malignant cells. Here, we review the progress being made in addressing challenges posed by targeting the surface carbohydrates of bacteria, protozoa, helminths, viruses, fungi and cancer cells for vaccine purposes.
12. Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer ...
... vaccination against COVID-19, particularly in mRNA vaccines. In addition ... Zhang, Z.; Mateus, J.; Coelho, C.H.; Dan, J.M.; Moderbacher, C.R.; Gálvez ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked a global pandemic identified as coronavirus disease (COVID-19), with millions of deaths worldwide. However, several important questions regarding its impact on public health remain unanswered, such as the impact of vaccination on vulnerable subpopulations such as cancer patients. Cytokine storm and a sustained inflammatory state are commonly associated with immune cell depletion, being manifested in most immunocompromised individuals. This strong immunosuppression can lead to a dysfunctional antiviral response to natural viral infection and compromised vaccination response. Extracellular vesicles (EVs) are membrane-bound vesicles released from cells that are involved in intercellular communication. EVs carry various molecules including microRNAs that play a crucial role in COVID-19 pathophysiology, influencing cellular responses. This review summarizes the state of the art concerning the role of EV-derived miRNAs in COVID-19 infection and their potential use as prognosis biomarkers for vaccination response in cancer patients.
13. The Moral Foundations of Vaccine Passports - IDEAS/RePEc
Our study can inform business and policy communication strategies of existing vaccine passports, general vaccine mandates, and similar measures in future ...
The debate around vaccine passports has been polarising and controversial. Although the measure allows businesses to resume in-person operations and enables transitioning out of lockdown due to the C
14. Publications | Johns Hopkins Center for Immunization Research
Anne Dunlop, Anne Palmer, Annie Sundelson, Annmarie Rosselli-Fraschilla, Anthony S. Fauci, Aparupa Sengupta, Arnold Hagens, Arrietta Chakos ...
All Publication Types
15. Jill Dunlop - Ontario has reached two million doses of #COVID19 ...
... vaccination sites and other health care partners ... Dan Barber. Isn't it amazing how our government ... Jill Dunlop profile picture · Jill Dunlop . 6h. ...
See posts, photos and more on Facebook.